On March 8, 2010
Sanofi, European Regulators to Bald Breast-Cancer Patients: Drop Dead
Sanofi-Aventis (SNY) says it is “unable” to disclose how many women are rendered permanently bald by its breast cancer drug Taxotere and the European Medicines Agency (EMEA) says such data “are not routinely collected” even though small studies suggest that
…
0 Comments